The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3050, Australia.
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3050, Australia.
Semin Cell Dev Biol. 2021 Jan;109:76-85. doi: 10.1016/j.semcdb.2020.08.008. Epub 2020 Sep 23.
Over the last two decades the mechanisms that underpin cell survival and cell death have been intensively studied. One molecule in particular, Receptor Interacting Protein Kinase 1 (RIPK1), has gained interest due to the ability to function upstream of both NF-κB signaling and caspase-dependent and -independent cell death. RIPK1 is critical in determining cell fate downstream of cytokine signaling receptors such as the Tumour Necrosis Factor Receptor Super Family (TNFRSF) and the innate immune Toll-like receptors. Various studies have attempted to untangle how ubiquitination of RIPK1 dictates signaling outcomes; however, due to the complex nature of ubiquitin signaling it has been difficult to prove that ubiquitination of RIPK1 does in fact influence signaling outcomes. Therefore, we ask the question: What do we really know about RIPK1 ubiquitination, and, to what extent can we conclude that ubiquitination of RIPK1 impacts RIPK1-mediated signaling events?
在过去的二十年中,细胞存活和细胞死亡的机制一直受到深入研究。特别是一种分子,受体相互作用蛋白激酶 1(RIPK1),由于能够在上游发挥作用 NF-κB 信号和胱天蛋白酶依赖性和非依赖性细胞死亡。RIPK1 在决定细胞命运方面至关重要下游细胞因子信号受体,如肿瘤坏死因子受体超家族(TNFRSF)和先天免疫 Toll 样受体。各种研究试图解开 RIPK1 泛素化如何决定信号转导结果; 然而,由于泛素信号的复杂性质,很难证明 RIPK1 的泛素化实际上会影响信号转导结果。因此,我们提出了一个问题:我们对 RIPK1 泛素化的了解程度如何,以及在多大程度上可以得出结论,即 RIPK1 的泛素化会影响 RIPK1 介导的信号事件?